Microarray analysis of bone marrow-derived macrophage cells treated with Kdo2-lipid A (KLA) and ATP

Search by fold change ratio | Search by KEGG pathway | Search by LIPID MAPS lipid pathway

Kdo2-Lipid A / ATP gene array data - treatment:control ratios

KEGG pathway: Insulin signaling pathway (mmu04910)

Legend:graph_icon: View data/graphs for replicates
Gene symbol    Time course plot Accession Description Treatment 15min 30min 1hr 2hr 4hr 8hr 20hr
4932417H
02Rik
KLA  ATP  ATP+KLA
 AK029341 0 day neonate head cDNA, RIKEN full-length enriched library, clone:4832440O09 product:Hypothetical ARM repeat structure containing protein, full insert sequence. [AK029341] KLA .90 .86 .81 .84 .93 .84 .93
ATP 1.00 1.06 1.02 .88 .93 .76 1.06
KLA/ATP .90 .86 .88 .79 .83 .80 .98
4932417H
02Rik
KLA  ATP  ATP+KLA
 NM_028898 RIKEN cDNA 4932417H02 gene (4932417H02Rik), mRNA [NM_028898] KLA .76 .72 .83 .63 .61 .68 .75
ATP .99 .95 .79 .76 .66 .62 1.47
KLA/ATP .78 .71 .56 .50 .39 .48 .89
Acaca
KLA  ATP  ATP+KLA
 NM_133360 acetyl-Coenzyme A carboxylase alpha (Acaca), mRNA [NM_133360] KLA .99 .94 .95 .93 .95 1.00 1.00
ATP .98 .97 .96 .93 .92 .96 .99
KLA/ATP 1.01 .96 .99 .92 .93 .94 .91
Acacb
KLA  ATP  ATP+KLA
 NM_133904 acetyl-Coenzyme A carboxylase beta (Acacb), mRNA [NM_133904] KLA 1.01 .93 1.00 .99 .95 1.03 .92
ATP .96 1.04 1.05 .98 1.04 1.11 1.05
KLA/ATP .90 1.01 1.05 1.03 .97 .96 1.08
AK045366
KLA  ATP  ATP+KLA
 AK045366 adult male corpora quadrigemina cDNA, RIKEN full-length enriched library, clone:B230107A03 product:unclassifiable, full insert sequence [AK045366] KLA .88 .80 .79 .86 .89 .97 1.07
ATP 1.21 1.67 2.40 3.50 2.58 1.29 1.12
KLA/ATP .97 .98 1.30 1.76 1.26 1.15 1.06
Akt1
KLA  ATP  ATP+KLA
 NM_009652 thymoma viral proto-oncogene 1 (Akt1), mRNA [NM_009652] KLA .80 .80 .75 .75 .71 .70 .82
ATP 1.00 1.02 .76 .85 .76 .68 .84
KLA/ATP .82 .80 .64 .68 .67 .61 .72
Akt2
KLA  ATP  ATP+KLA
 NM_007434 thymoma viral proto-oncogene 2 (Akt2), transcript variant 2, mRNA [NM_007434] KLA 1.45 1.49 1.81 1.61 1.83 1.17 .92
ATP 1.12 1.12 1.00 1.28 1.20 .94 1.06
KLA/ATP 1.48 1.70 1.69 1.58 1.57 1.32 1.27
Akt3
KLA  ATP  ATP+KLA
 NM_011785 thymoma viral proto-oncogene 3 (Akt3), mRNA [NM_011785] KLA 3.42 3.45 5.31 5.16 4.65 3.80 2.12
ATP 1.12 1.22 1.10 1.37 1.02 1.11 1.56
KLA/ATP 3.72 4.17 4.62 4.64 2.74 2.05 3.82
Araf
KLA  ATP  ATP+KLA
 NM_009703 v-raf murine sarcoma 3611 viral oncogene homolog (Araf), mRNA [NM_009703] KLA .87 .80 .89 .93 1.10 1.19 1.16
ATP 1.09 1.11 1.19 1.18 .78 .53 1.18
KLA/ATP 1.00 .95 .99 .93 .63 .55 1.27
Bad
KLA  ATP  ATP+KLA
 AK029400 0 day neonate head cDNA, RIKEN full-length enriched library, clone:4833429M11 product:Bcl-associated death promoter, full insert sequence. [AK029400] KLA 1.15 1.22 1.26 1.31 1.40 1.67 1.59
ATP .95 1.06 1.12 1.06 .78 .89 1.27
KLA/ATP 1.25 1.39 1.33 1.29 1.11 .91 1.38
Braf
KLA  ATP  ATP+KLA
 NM_139294 Braf transforming gene (Braf), mRNA [NM_139294] KLA 1.52 1.57 1.55 1.33 1.83 1.52 1.60
ATP 1.08 1.17 1.02 1.37 .95 1.15 .95
KLA/ATP 1.64 1.69 1.39 1.51 1.04 1.31 1.26
Calm1
KLA  ATP  ATP+KLA
 NM_009790 calmodulin 1 (Calm1), mRNA [NM_009790] KLA 1.20 1.26 1.30 1.06 1.16 1.09 1.18
ATP 1.07 1.20 1.00 1.29 .99 .64 .58
KLA/ATP 1.31 1.31 .93 1.31 .97 .83 .59
Calm2
KLA  ATP  ATP+KLA
 NM_007589 calmodulin 2 (Calm2), mRNA [NM_007589] KLA .79 .81 .71 .67 .54 .45 .64
ATP .99 1.03 1.04 .93 .82 .52 .76
KLA/ATP .76 .78 .76 .77 .73 .47 .42
Calm3
KLA  ATP  ATP+KLA
 NM_007590 calmodulin 3 (Calm3), mRNA [NM_007590] KLA .95 .96 .93 1.03 1.05 1.08 1.00
ATP .93 .96 .99 .97 .93 .84 .72
KLA/ATP .89 .93 .90 .91 1.02 .98 .70
Calm4
KLA  ATP  ATP+KLA
 NM_020036 calmodulin 4 (Calm4), mRNA [NM_020036] KLA 1.02 .96 1.05 1.00 .99 1.00 1.01
ATP 1.10 1.05 1.03 1.01 .94 .98 .98
KLA/ATP .99 1.12 1.01 1.03 .98 1.07 1.02
Calm5
KLA  ATP  ATP+KLA
 NM_001008706 calmodulin 5 (Calm5), mRNA [NM_001008706] KLA 1.02 1.11 .99 .98 1.07 1.01 1.09
ATP 1.07 1.05 1.04 1.04 1.01 1.04 .99
KLA/ATP 1.00 1.00 .97 1.07 1.00 1.07 .98
Calml3
KLA  ATP  ATP+KLA
 NM_027416 calmodulin-like 3 (Calml3), mRNA [NM_027416] KLA 1.01 .95 1.05 .91 1.01 .98 .89
ATP .91 1.05 1.04 1.01 .93 1.07 .99
KLA/ATP 1.01 .96 .97 .96 .97 .92 .99
Cbl
KLA  ATP  ATP+KLA
 NM_007619 Casitas B-lineage lymphoma (Cbl), mRNA [NM_007619] KLA 1.23 1.22 1.54 1.84 2.25 2.58 2.75
ATP 1.04 1.12 1.07 1.53 1.55 2.12 3.23
KLA/ATP 1.23 1.20 1.22 1.44 1.31 1.88 6.28
Cblb
KLA  ATP  ATP+KLA
 AK045005 9.5 days embryo parthenogenote cDNA, RIKEN full-length enriched library, clone:B130018P07 product:hypothetical protein, full insert sequence. [AK045005] KLA 1.16 1.11 1.15 1.10 1.16 .98 .93
ATP 1.16 1.23 .98 1.28 1.34 .73 1.55
KLA/ATP 1.26 1.60 1.64 1.23 1.01 .91 1.05
Cblb
KLA  ATP  ATP+KLA
 AK084162 12 days embryo eyeball cDNA, RIKEN full-length enriched library, clone:D230004I05 product:unclassifiable, full insert sequence. [AK084162] KLA .97 .98 1.02 1.01 .84 1.02 1.03
ATP 1.03 1.02 .98 1.09 1.05 .96 .96
KLA/ATP 1.07 .95 .91 .98 .98 1.01 1.00
Cblc
KLA  ATP  ATP+KLA
 NM_023224 Casitas B-lineage lymphoma c (Cblc), mRNA [NM_023224] KLA 1.02 .98 1.01 1.02 1.00 .99 1.05
ATP .94 .95 .97 1.04 .99 .97 .99
KLA/ATP 1.00 1.01 .96 .97 .94 .92 .99
Crk
KLA  ATP  ATP+KLA
 NM_133656 v-crk sarcoma virus CT10 oncogene homolog (avian) (Crk), mRNA [NM_133656] KLA 1.29 1.32 1.41 1.38 1.75 1.59 1.52
ATP 1.08 1.17 1.01 .93 1.27 2.11 1.70
KLA/ATP 1.37 1.49 1.14 1.09 1.21 1.69 2.32
Crkl
KLA  ATP  ATP+KLA
 NM_007764 v-crk sarcoma virus CT10 oncogene homolog (avian)-like (Crkl), mRNA [NM_007764] KLA 1.85 1.97 2.08 1.73 1.66 1.64 1.36
ATP .97 .94 .78 .74 1.46 1.89 1.46
KLA/ATP 1.92 1.88 1.18 1.44 1.67 2.65 2.72
Eif4e
KLA  ATP  ATP+KLA
 NM_007917 eukaryotic translation initiation factor 4E (Eif4e), mRNA [NM_007917] KLA 1.22 1.06 .94 .97 .83 .85 1.18
ATP 1.00 1.01 1.27 1.27 2.61 2.08 .97
KLA/ATP .95 1.04 1.37 1.16 1.50 1.28 .73
Eif4e2
KLA  ATP  ATP+KLA
 NM_001039169 eukaryotic translation initiation factor 4E member 2 (Eif4e2), transcript variant 2, mRNA [NM_001039169] KLA 1.53 1.51 1.54 1.52 1.55 1.49 1.55
ATP 1.02 1.08 1.12 1.45 1.61 1.51 1.15
KLA/ATP 1.56 1.60 1.59 1.90 1.90 1.75 1.68
Eif4e2
KLA  ATP  ATP+KLA
 NM_023314 eukaryotic translation initiation factor 4E member 2 (Eif4e2), transcript variant 3, mRNA [NM_023314] KLA 1.42 1.40 1.43 1.35 1.58 1.65 1.42
ATP 1.06 1.06 1.04 .98 1.41 2.07 2.04
KLA/ATP 1.46 1.48 1.40 1.45 1.64 2.12 2.30
Eif4ebp1
KLA  ATP  ATP+KLA
 NM_007918 eukaryotic translation initiation factor 4E binding protein 1 (Eif4ebp1), mRNA [NM_007918] KLA .66 .64 .59 .67 .81 .97 .97
ATP .97 .94 1.10 1.05 1.99 1.60 .91
KLA/ATP .62 .61 .68 .68 1.50 1.24 .95
Elk1
KLA  ATP  ATP+KLA
 AK082260 0 day neonate cerebellum cDNA, RIKEN full-length enriched library, clone:C230030F12 product:ELK1, member of ETS oncogene family, full insert sequence. [AK082260] KLA 1.02 1.01 1.01 .97 1.00 1.03 1.06
ATP 1.02 1.07 1.06 1.03 1.02 1.02 1.00
KLA/ATP 1.08 .99 .97 1.01 1.02 1.06 .95
Exoc7
KLA  ATP  ATP+KLA
 NM_016857 exocyst complex component 7 (Exoc7), mRNA [NM_016857] KLA 1.12 1.15 1.17 1.05 1.15 1.19 1.08
ATP .99 .96 1.07 1.18 .78 .70 1.13
KLA/ATP 1.09 1.10 1.22 1.22 .89 .78 1.34
Fasn
KLA  ATP  ATP+KLA
 NM_007988 fatty acid synthase (Fasn), mRNA [NM_007988] KLA .51 .49 .46 .44 .41 .35 .41
ATP .98 .93 .98 .96 .83 .67 .62
KLA/ATP .52 .47 .48 .58 .51 .44 .25
Fbp1
KLA  ATP  ATP+KLA
 NM_019395 fructose bisphosphatase 1 (Fbp1), mRNA [NM_019395] KLA .91 .95 1.03 1.01 1.00 1.02 .80
ATP .96 .96 .99 .95 .86 .84 .64
KLA/ATP .88 .96 .87 .92 .92 .84 .70
Fbp2
KLA  ATP  ATP+KLA
 NM_007994 fructose bisphosphatase 2 (Fbp2), mRNA [NM_007994] KLA 1.03 1.03 .95 1.02 1.02 1.03 1.06
ATP 1.03 1.03 1.05 1.01 .97 1.01 1.17
KLA/ATP .96 .92 1.06 .85 1.07 .97 1.12
Flot1
KLA  ATP  ATP+KLA
 NM_008027 flotillin 1 (Flot1), mRNA [NM_008027] KLA 1.01 1.10 1.16 1.16 1.82 2.12 1.71
ATP 1.02 1.03 .75 .90 .84 .75 1.19
KLA/ATP 1.14 1.09 .87 1.13 1.05 1.02 .88
Flot2
KLA  ATP  ATP+KLA
 NM_008028 flotillin 2 (Flot2), transcript variant 2, mRNA [NM_008028] KLA .93 .97 .99 1.01 1.15 .97 1.15
ATP 1.25 1.45 .81 1.22 1.04 .87 .76
KLA/ATP 1.03 1.14 .64 1.06 .71 .92 1.19
Foxo1
KLA  ATP  ATP+KLA
 NM_019739 forkhead box O1 (Foxo1), mRNA [NM_019739] KLA .60 .55 .60 .58 .49 .60 .71
ATP .96 1.03 1.08 1.03 2.49 1.70 .98
KLA/ATP .56 .58 .67 .83 1.47 1.57 .97
Frap1
KLA  ATP  ATP+KLA
 NM_020009 FK506 binding protein 12-rapamycin associated protein 1 (Frap1), mRNA [NM_020009] KLA 1.37 1.32 1.46 1.57 1.83 1.29 1.28
ATP 1.12 1.07 .95 .91 .80 .77 1.03
KLA/ATP 1.45 1.51 1.50 1.11 .89 .87 1.01
G6pc
KLA  ATP  ATP+KLA
 NM_008061 glucose-6-phosphatase, catalytic (G6pc), mRNA [NM_008061] KLA .96 .94 1.04 1.07 1.09 1.06 1.02
ATP .98 1.05 1.09 1.04 1.05 1.00 1.01
KLA/ATP 1.03 1.05 1.06 .96 1.02 1.00 .99
G6pc2
KLA  ATP  ATP+KLA
 NM_021331 glucose-6-phosphatase, catalytic, 2 (G6pc2), mRNA [NM_021331] KLA .99 1.03 1.00 .98 .95 1.02 .98
ATP .95 1.06 .97 1.08 1.16 1.26 1.04
KLA/ATP .94 .99 1.05 6.99 3.55 1.48 1.11
G6pc3
KLA  ATP  ATP+KLA
 NM_175935 glucose 6 phosphatase, catalytic, 3 (G6pc3), mRNA [NM_175935] KLA .88 .89 .89 .80 .75 .68 .88
ATP .99 1.05 .95 1.14 .92 .64 .81
KLA/ATP .92 .90 .79 .94 .70 .62 .58
Gck
KLA  ATP  ATP+KLA
 NM_010292 glucokinase (Gck), mRNA [NM_010292] KLA 1.03 .99 1.04 1.02 .97 .98 1.00
ATP 1.01 .97 1.08 .99 1.06 .98 .96
KLA/ATP 1.06 1.01 .96 .98 .98 1.01 1.01
Grb2
KLA  ATP  ATP+KLA
 NM_008163 growth factor receptor bound protein 2 (Grb2), mRNA [NM_008163] KLA .92 .88 .90 1.27 1.43 1.22 1.00
ATP 1.02 .83 .51 .42 .92 .70 .57
KLA/ATP .84 .77 .61 .56 1.56 1.49 .52
Grb2
KLA  ATP  ATP+KLA
 U07617 Grb2 adaptor protein (grb2) mRNA, complete cds. [U07617] KLA .83 .80 .95 1.13 1.38 1.36 1.06
ATP .84 .74 .51 .41 .82 .74 .59
KLA/ATP .77 .70 .57 .54 1.49 1.39 .53
Gsk3b
KLA  ATP  ATP+KLA
 NM_019827 glycogen synthase kinase 3 beta (Gsk3b), mRNA [NM_019827] KLA 1.06 1.03 1.11 1.01 1.26 1.28 1.26
ATP 1.18 1.27 1.15 2.07 2.37 2.32 1.67
KLA/ATP 1.15 1.21 .98 1.50 1.67 2.50 2.99
Gys1
KLA  ATP  ATP+KLA
 NM_030678 glycogen synthase 1, muscle (Gys1), mRNA [NM_030678] KLA .89 .89 .88 .80 .91 1.07 1.78
ATP 1.02 1.15 .91 1.01 .72 .73 1.14
KLA/ATP .96 .94 .73 .87 .63 .64 1.24
Gys2
KLA  ATP  ATP+KLA
 NM_145572 glycogen synthase 2 (Gys2), mRNA [NM_145572] KLA 1.01 .96 .99 1.06 1.02 1.00 .92
ATP .99 .98 .98 1.02 .95 1.12 1.10
KLA/ATP 1.03 .97 1.00 1.03 1.01 1.05 1.09
Hk1
KLA  ATP  ATP+KLA
 J05277 gb|Mouse hexokinase mRNA, complete cds [J05277] KLA 1.49 1.45 1.66 1.78 1.51 1.29 .99
ATP 1.11 1.05 1.15 1.20 2.31 2.17 1.09
KLA/ATP 1.63 1.51 1.70 1.47 1.94 1.92 1.40
Hk1
KLA  ATP  ATP+KLA
 NM_010438 hexokinase 1 (Hk1), nuclear gene encoding mitochondrial protein, mRNA [NM_010438] KLA 1.58 1.75 2.05 1.84 1.96 1.67 1.31
ATP 1.06 1.25 1.01 1.49 2.23 1.79 1.20
KLA/ATP 1.87 1.96 1.51 1.93 1.71 1.94 1.72
Hk2
KLA  ATP  ATP+KLA
 NM_013820 hexokinase 2 (Hk2), mRNA [NM_013820] KLA 4.09 4.09 3.17 2.37 1.53 1.62 2.02
ATP .98 .92 1.08 2.24 3.82 3.86 .97
KLA/ATP 4.07 3.94 4.17 3.53 5.42 4.65 1.54
Hk3
KLA  ATP  ATP+KLA
 NM_001033245 hexokinase 3 (Hk3), nuclear gene encoding mitochondrial protein, mRNA [NM_001033245] KLA 1.52 1.68 1.94 1.85 2.21 2.89 1.98
ATP 1.01 1.07 .87 .99 1.01 1.26 2.62
KLA/ATP 1.63 1.74 1.67 1.69 1.44 2.01 3.53
Hkdc1
KLA  ATP  ATP+KLA
 NM_145419 hexokinase domain containing 1 (Hkdc1), mRNA [NM_145419] KLA 1.10 1.08 1.12 1.12 1.02 1.07 1.04
ATP .96 1.04 1.06 4.28 10.50 3.91 1.34
KLA/ATP .98 1.04 1.14 5.33 12.44 8.68 1.77
Hras1
KLA  ATP  ATP+KLA
 NM_008284 Harvey rat sarcoma virus oncogene 1 (Hras1), mRNA [NM_008284] KLA .79 .82 .77 .82 .94 1.03 1.07
ATP 1.01 .95 .69 .83 .79 1.12 1.15
KLA/ATP .84 .77 .61 .65 .82 1.00 1.05
Ikbkb
KLA  ATP  ATP+KLA
 NM_010546 inhibitor of kappaB kinase beta (Ikbkb), mRNA [NM_010546] KLA 1.88 2.10 2.14 1.83 1.73 1.31 1.19
ATP .81 .74 .55 .49 .59 1.05 .96
KLA/ATP 1.86 1.73 1.39 1.12 .89 1.17 1.24
Inppl1
KLA  ATP  ATP+KLA
 NM_010567 inositol polyphosphate phosphatase-like 1 (Inppl1), transcript variant 1, mRNA [NM_010567] KLA .82 .80 .73 .81 .79 .72 .94
ATP 1.05 1.04 .69 .58 .56 .87 .98
KLA/ATP .90 .83 .58 .46 .87 1.07 1.34
Ins1
KLA  ATP  ATP+KLA
 NM_008386 insulin I (Ins1), mRNA [NM_008386] KLA 1.00 .99 .99 1.03 1.01 .98 1.06
ATP .97 1.03 1.00 1.03 .99 1.07 1.05
KLA/ATP 1.03 .93 .98 1.04 1.07 1.03 1.01
Ins2
KLA  ATP  ATP+KLA
 NM_008387 insulin II (Ins2), mRNA [NM_008387] KLA .99 1.00 1.00 1.01 1.00 1.02 1.00
ATP 1.01 .99 1.00 1.00 .98 .99 1.01
KLA/ATP .99 1.01 1.00 .98 .99 .99 .98
Insr
KLA  ATP  ATP+KLA
 NM_010568 insulin receptor (Insr), mRNA [NM_010568] KLA .75 .81 .77 .69 .69 .69 .83
ATP 1.07 1.06 .88 .79 .73 .77 .83
KLA/ATP .80 .80 .72 .71 .64 .64 .70
Irs1
KLA  ATP  ATP+KLA
 NM_010570 insulin receptor substrate 1 (Irs1), mRNA [NM_010570] KLA .97 .96 .99 1.01 .93 .94 .94
ATP 1.00 .99 1.02 .96 .96 .94 .91
KLA/ATP .96 .96 .98 .96 .97 .98 .92
Irs3
KLA  ATP  ATP+KLA
 NM_010571 insulin receptor substrate 3 (Irs3), mRNA [NM_010571] KLA 1.02 .92 1.00 .97 .93 .94 .95
ATP .95 1.06 1.05 .88 .95 .99 .99
KLA/ATP .89 .88 .96 .94 .88 .90 .97
Irs4
KLA  ATP  ATP+KLA
 NM_010572 insulin receptor substrate 4 (Irs4), mRNA [NM_010572] KLA 1.06 1.14 1.08 1.15 1.09 1.22 1.06
ATP .99 .98 1.19 1.10 1.15 1.18 1.05
KLA/ATP 1.02 1.10 1.26 1.19 1.22 1.32 1.18
Kras
KLA  ATP  ATP+KLA
 NM_021284 v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (Kras), mRNA [NM_021284] KLA .53 .49 .40 .42 .49 .95 1.05
ATP .98 1.01 1.16 1.17 1.39 1.29 1.74
KLA/ATP .50 .47 .50 .56 1.00 1.24 1.58
Lipe
KLA  ATP  ATP+KLA
 NM_010719 lipase, hormone sensitive (Lipe), transcript variant 1, mRNA [NM_010719] KLA 2.36 2.54 3.08 2.85 2.98 2.82 1.81
ATP 1.06 1.13 .98 1.19 .96 1.61 2.04
KLA/ATP 2.71 2.84 2.49 2.92 1.84 2.62 3.39
Map2k1
KLA  ATP  ATP+KLA
 NM_008927 mitogen-activated protein kinase kinase 1 (Map2k1), mRNA [NM_008927] KLA 1.82 2.00 2.31 2.03 2.51 2.20 1.51
ATP .99 1.14 .81 .87 .90 1.57 1.11
KLA/ATP 1.90 2.03 1.50 1.93 1.63 2.03 2.06
Map2k2
KLA  ATP  ATP+KLA
 NM_023138 mitogen-activated protein kinase kinase 2 (Map2k2), mRNA [NM_023138] KLA .96 1.01 1.09 .99 1.11 1.15 1.42
ATP 1.07 1.05 .74 .86 1.04 1.16 1.21
KLA/ATP 1.14 1.03 .68 .78 .85 1.01 1.20
Mapk1
KLA  ATP  ATP+KLA
 NM_001038663 mitogen-activated protein kinase 1 (Mapk1), transcript variant 2, mRNA [NM_001038663] KLA .97 1.03 .93 .86 .79 1.01 1.04
ATP .96 1.18 1.01 1.13 .84 1.04 1.16
KLA/ATP .99 .99 .84 .87 .63 .96 1.26
Mapk1
KLA  ATP  ATP+KLA
 NM_011949 mitogen-activated protein kinase 1 (Mapk1), transcript variant 1, mRNA [NM_011949] KLA .88 .80 .80 .73 .75 .76 .65
ATP .97 .96 1.06 .88 .90 .68 .48
KLA/ATP .82 .81 .78 .65 .64 .64 .45
Mapk10
KLA  ATP  ATP+KLA
 AK076990 adult male testis cDNA, RIKEN full-length enriched library, clone:4930597C01 product:mitogen activated protein kinase 10, full insert sequence. [AK076990] KLA 1.03 1.05 .98 1.04 .94 .95 1.02
ATP 1.00 .99 1.06 .97 1.01 .96 .99
KLA/ATP 1.07 1.01 .95 1.05 .82 .95 .87
Mapk10
KLA  ATP  ATP+KLA
 NM_009158 mitogen-activated protein kinase 10 (Mapk10), transcript variant 1, mRNA [NM_009158] KLA .95 1.00 .97 1.01 .99 1.01 .95
ATP 1.01 1.02 .98 1.01 1.04 1.01 .99
KLA/ATP 1.05 .99 1.01 .98 .92 .97 .98
Mapk3
KLA  ATP  ATP+KLA
 NM_011952 mitogen-activated protein kinase 3 (Mapk3), mRNA [NM_011952] KLA .81 .85 .88 .72 .79 .73 .90
ATP 1.13 1.30 .92 1.48 1.08 .68 1.03
KLA/ATP 1.01 1.01 .66 1.13 .77 .77 1.16
Mapk8
KLA  ATP  ATP+KLA
 AK162915 adult male spinal cord cDNA, RIKEN full-length enriched library, clone:A330031O19 product:mitogen activated protein kinase 8, full insert sequence [AK162915] KLA .94 .86 .80 .83 .77 .85 .83
ATP 1.08 1.12 .94 .80 .83 .71 .75
KLA/ATP .83 .81 .80 .74 .74 .75 .67
Mapk8
KLA  ATP  ATP+KLA
 AK163829 16 days embryo head cDNA, RIKEN full-length enriched library, clone:C130070A06 product:mitogen activated protein kinase 8, full insert sequence [AK163829] KLA .65 .61 .66 .70 .90 1.02 1.03
ATP .99 .94 1.68 1.44 1.75 1.84 1.10
KLA/ATP .63 .67 1.11 1.00 2.01 1.68 1.15
Mapk8
KLA  ATP  ATP+KLA
 NM_016700 mitogen-activated protein kinase 8 (Mapk8), mRNA [NM_016700] KLA .96 1.00 .94 .96 .94 .99 1.04
ATP 1.01 1.05 1.01 .99 1.03 .98 1.02
KLA/ATP .96 .97 .96 .97 .93 .94 .96
Mapk9
KLA  ATP  ATP+KLA
 NM_016961 mitogen-activated protein kinase 9 (Mapk9), transcript variant 2, mRNA [NM_016961] KLA 1.28 1.37 1.59 1.60 1.61 1.43 1.38
ATP 1.03 .99 .74 .71 .79 1.20 1.01
KLA/ATP 1.53 1.30 1.07 .99 .83 1.10 1.40
Mapk9
KLA  ATP  ATP+KLA
 NM_207692 mitogen-activated protein kinase 9 (Mapk9), transcript variant 1, mRNA [NM_207692] KLA 1.39 1.53 1.69 1.69 1.55 1.44 1.51
ATP .95 .92 .75 .85 .70 1.46 1.17
KLA/ATP 1.37 1.35 .99 1.18 .91 1.22 1.62
Mknk1
KLA  ATP  ATP+KLA
 NM_021461 MAP kinase-interacting serine/threonine kinase 1 (Mknk1), mRNA [NM_021461] KLA .78 .81 .88 .86 .98 1.12 .93
ATP 1.04 1.03 1.03 1.07 .70 .67 1.09
KLA/ATP .83 .83 .81 .84 .66 .88 1.12
Mknk2
KLA  ATP  ATP+KLA
 NM_021462 MAP kinase-interacting serine/threonine kinase 2 (Mknk2), mRNA [NM_021462] KLA .19 .18 .16 .15 .20 .50 .62
ATP .89 .86 1.35 2.05 1.76 1.52 1.29
KLA/ATP .19 .17 .32 .99 1.61 2.33 1.97
Mm.21312
8
KLA  ATP  ATP+KLA
 141801344 Unknown KLA .96 .95 .83 .77 .52 .99 1.32
ATP .80 .82 1.09 .80 .83 1.19 1.46
KLA/ATP .78 .92 .98 .62 .71 .94 1.41
Mm.22094
6
KLA  ATP  ATP+KLA
 27545180 Unknown KLA 1.00 .93 .97 1.05 1.06 1.29 1.13
ATP .90 .94 1.25 1.18 .85 .62 1.20
KLA/ATP .86 .99 1.14 .99 .83 .70 1.26
Mm.25381
9
KLA  ATP  ATP+KLA
 118130676 Unknown KLA 1.81 1.88 1.96 1.62 1.89 2.44 1.56
ATP .92 .91 1.24 1.01 1.16 2.06 1.95
KLA/ATP 1.62 1.86 1.86 1.41 1.89 2.37 1.97
Mm.26687
1
KLA  ATP  ATP+KLA
 80978931 Unknown KLA .67 .63 .70 .83 1.66 1.43 1.54
ATP 1.20 1.24 1.22 1.26 1.80 .81 1.02
KLA/ATP .63 .56 .83 1.06 1.26 .70 1.34
Mm.27791
6
KLA  ATP  ATP+KLA
 133505844 Unknown KLA .72 .68 .80 1.17 1.52 1.33 1.19
ATP .85 .76 .85 .58 1.10 1.47 .53
KLA/ATP .61 .62 .79 .68 1.96 1.74 .48
Mm.30616
3
KLA  ATP  ATP+KLA
 31543508 Unknown KLA .75 .79 .72 .74 .73 .95 1.15
ATP .93 .93 1.13 1.15 1.30 1.17 1.64
KLA/ATP .78 .83 .82 .86 1.02 1.17 1.18
Mm.3159
KLA  ATP  ATP+KLA
 77404187 Unknown KLA .96 .95 1.06 1.00 1.00 .91 1.05
ATP 1.06 .97 .97 .96 1.02 .90 1.05
KLA/ATP .92 .99 .96 .99 .99 .99 .98
Mm.4387
KLA  ATP  ATP+KLA
 133892666 Unknown KLA .85 .87 .85 .89 .77 .91 1.18
ATP 1.01 1.01 .87 1.07 .75 .86 .93
KLA/ATP .88 .86 .77 .81 .72 .91 .84
Mm.44266
8
KLA  ATP  ATP+KLA
 21703801 Unknown KLA .22 .18 .13 .12 .11 .16 .29
ATP .80 .65 .69 .53 .38 .54 .41
KLA/ATP .17 .15 .13 .11 .28 .48 .12
Mm.45825
9
KLA  ATP  ATP+KLA
 116292181 Unknown KLA .84 .86 .91 .85 .98 .98 1.00
ATP 1.05 1.06 .94 .95 1.00 .89 .89
KLA/ATP .92 .84 .87 .93 .91 .92 .82
Mm.47273
6
KLA  ATP  ATP+KLA
 94367764 Unknown KLA .83 .88 1.22 1.49 1.09 .93 .46
ATP .80 .57 .51 .23 .51 .97 .74
KLA/ATP .66 .62 1.00 .65 2.02 1.08 .37
Mm.81698
KLA  ATP  ATP+KLA
 158937287 Unknown KLA .95 1.02 1.04 .98 1.01 1.04 1.08
ATP 1.00 1.03 .97 1.00 1.03 .98 .96
KLA/ATP 1.07 1.00 .94 .98 1.03 1.05 .97
Nras
KLA  ATP  ATP+KLA
 NM_010937 neuroblastoma ras oncogene (Nras), mRNA [NM_010937] KLA 1.20 1.22 1.27 1.20 1.09 .91 .84
ATP .98 .91 .69 .61 .59 .67 .78
KLA/ATP 1.22 1.14 .97 .79 .73 .61 .72
Pck2
KLA  ATP  ATP+KLA
 NM_028994 phosphoenolpyruvate carboxykinase 2 (mitochondrial) (Pck2), nuclear gene encoding mitochondrial protein, mRNA [NM_028994] KLA .40 .37 .32 .28 .37 .56 .55
ATP .99 .96 .86 .94 1.02 .57 .77
KLA/ATP .40 .37 .31 .35 .42 .35 .46
Pde3a
KLA  ATP  ATP+KLA
 AK004638 adult male lung cDNA, RIKEN full-length enriched library, clone:1200007J10 product:phosphodiesterase 3A, cGMP inhibited, full insert sequence. [AK004638] KLA .96 .94 .95 1.07 1.01 1.00 1.03
ATP 1.02 .95 .96 1.07 .97 .96 1.01
KLA/ATP 1.00 1.00 1.02 .94 .98 .99 1.01
Pde3a
KLA  ATP  ATP+KLA
 AK052718 0 day neonate kidney cDNA, RIKEN full-length enriched library, clone:D630035A07 product:inferred: phosphodiesterase 3A, cGMP inhibited, full insert sequence. [AK052718] KLA .93 1.02 .94 1.00 .98 1.03 .96
ATP 1.03 .96 1.00 .98 1.00 1.03 1.01
KLA/ATP .98 1.06 1.08 1.03 .94 .98 .89
Pde3a
KLA  ATP  ATP+KLA
 NM_018779 phosphodiesterase 3A, cGMP inhibited (Pde3a), mRNA [NM_018779] KLA 1.01 1.09 .98 .98 .93 1.03 1.09
ATP .99 .97 1.04 1.05 .96 .96 1.06
KLA/ATP 1.06 .97 .94 1.09 1.00 1.06 .96
Pde3b
KLA  ATP  ATP+KLA
 AK044183 10 days neonate cortex cDNA, RIKEN full-length enriched library, clone:A830097M14 product:phosphodiesterase 3B, cGMP-inhibited, full insert sequence. [AK044183] KLA .98 .99 1.04 .99 .93 1.01 .96
ATP 1.08 .96 .92 .93 .93 .90 .93
KLA/ATP .97 .94 .95 .89 .92 .89 .95
Pde3b
KLA  ATP  ATP+KLA
 NM_011055 phosphodiesterase 3B, cGMP-inhibited (Pde3b), mRNA [NM_011055] KLA 1.02 1.01 .95 1.00 .88 .75 .59
ATP 1.12 1.20 1.09 1.04 .71 .95 .81
KLA/ATP .90 .92 1.00 .94 .74 .85 .93
Pdpk1
KLA  ATP  ATP+KLA
 NM_011062 3-phosphoinositide dependent protein kinase-1 (Pdpk1), transcript variant 1, mRNA [NM_011062] KLA .90 .90 .84 1.00 1.32 1.19 1.15
ATP 1.05 1.09 1.04 1.14 1.31 .97 1.17
KLA/ATP .90 .89 .91 1.02 1.27 .96 1.42
Phka1
KLA  ATP  ATP+KLA
 NM_008832 phosphorylase kinase alpha 1 (Phka1), transcript variant 1, mRNA [NM_008832] KLA .89 .77 .77 .83 .74 .79 .89
ATP 1.10 1.03 .90 .88 .69 .72 .79
KLA/ATP .83 .78 .80 .70 .67 .76 .66
Phka2
KLA  ATP  ATP+KLA
 AK045618 adult male corpora quadrigemina cDNA, RIKEN full-length enriched library, clone:B230216B06 product:PHOSPHORYLASE B KINASE ALPHA REGULATORY CHAIN, LIVER ISOFORM (PHOSPHORYLASE KINASE ALPHA L SUBUNIT)homolog [Homo sapiens], full insert sequ KLA .48 .47 .52 .56 .57 .60 .48
ATP .79 .70 .60 .56 .50 .49 .58
KLA/ATP .45 .46 .53 .55 .58 .48 .47
Phka2
KLA  ATP  ATP+KLA
 NM_172783 phosphorylase kinase alpha 2 (Phka2), mRNA [NM_172783] KLA .66 .67 .61 .52 .46 .48 .52
ATP 1.06 1.17 .74 .86 .45 .32 .60
KLA/ATP .76 .68 .42 .51 .31 .31 .50
Phkb
KLA  ATP  ATP+KLA
 AK089493 B6-derived CD11 +ve dendritic cells cDNA, RIKEN full-length enriched library, clone:F730039M10 product:similar to phosphorylase kinase (EC 2.7.1.38) beta chain [Homo sapiens], full insert sequence. [AK089493] KLA .90 .83 .71 .84 1.04 .89 .91
ATP .96 1.05 .83 .72 .77 .76 .85
KLA/ATP .87 .87 .76 .71 .78 .71 .77
Phkb
KLA  ATP  ATP+KLA
 NM_199446 phosphorylase kinase beta (Phkb), mRNA [NM_199446] KLA .94 .94 .95 .93 .83 .77 .79
ATP .96 1.02 .94 .86 .51 .38 .60
KLA/ATP .91 .93 .76 .71 .45 .38 .44
Phkg1
KLA  ATP  ATP+KLA
 NM_011079 phosphorylase kinase gamma 1 (Phkg1), mRNA [NM_011079] KLA 1.00 .98 1.06 1.06 .95 .99 .94
ATP 1.02 .98 .91 .99 1.00 .91 .96
KLA/ATP 1.02 1.11 1.01 .99 1.00 .92 1.09
Phkg2
KLA  ATP  ATP+KLA
 AK089062 2 days neonate thymus thymic cells cDNA, RIKEN full-length enriched library, clone:E430038C01 product:5phosphorylase kinase, gamma 2 (testis), full insert sequence [AK089062] KLA .93 .90 .88 .86 .99 .79 .89
ATP 1.10 1.05 .68 .73 1.05 .92 .98
KLA/ATP .87 .84 .69 .79 .93 .97 1.10
Phkg2
KLA  ATP  ATP+KLA
 NM_026888 phosphorylase kinase, gamma 2 (testis) (Phkg2), mRNA [NM_026888] KLA .88 .86 .98 .96 1.13 1.02 .92
ATP 1.19 1.12 1.02 1.23 1.17 1.23 1.22
KLA/ATP 1.04 1.06 1.00 1.13 1.25 1.33 1.64
Pik3ca
KLA  ATP  ATP+KLA
 ENSMUST00000108243 ens|Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (EC 2.7.1.153) (PI3-kinase p110 subunit alpha) (PtdIns-3- kinase p110) (PI3K). [Source:Uniprot/SWISSPROT;Acc:P42337] [ENSMUST00000108243] KLA 1.07 1.01 .91 .90 .98 .96 .86
ATP 1.03 .87 1.12 .63 1.22 1.86 .60
KLA/ATP 1.05 .82 .91 .61 1.17 1.26 .63
Pik3ca
KLA  ATP  ATP+KLA
 NM_008839 phosphatidylinositol 3-kinase, catalytic, alpha polypeptide (Pik3ca), mRNA [NM_008839] KLA 1.15 1.11 1.05 .82 .99 1.03 1.27
ATP .98 1.00 .79 .75 .96 1.32 1.10
KLA/ATP 1.10 .98 .64 .72 .80 1.20 1.41
Pik3cb
KLA  ATP  ATP+KLA
 NM_029094 phosphatidylinositol 3-kinase, catalytic, beta polypeptide (Pik3cb), mRNA [NM_029094] KLA 1.06 1.06 1.03 .73 .68 .98 1.69
ATP 1.04 1.21 .95 1.02 .85 .93 1.73
KLA/ATP 1.15 1.27 .73 .83 .58 .81 1.81
Pik3cd
KLA  ATP  ATP+KLA
 NM_008840 phosphatidylinositol 3-kinase catalytic delta polypeptide (Pik3cd), transcript variant 1, mRNA [NM_008840] KLA 2.28 2.42 3.10 4.17 3.35 2.31 1.34
ATP 1.02 .91 .99 .63 .30 .67 .80
KLA/ATP 2.14 2.23 2.70 1.51 1.17 .85 .72
Pik3cd
KLA  ATP  ATP+KLA
 U86587 phosphatidylinositol 3-kinase catalytic subunit p110 delta mRNA, complete cds. [U86587] KLA 2.21 2.24 3.71 3.17 3.67 2.66 1.48
ATP 1.00 1.03 .93 .96 .46 .75 .97
KLA/ATP 2.27 2.32 1.97 2.02 1.01 .99 .98
Pik3cg
KLA  ATP  ATP+KLA
 NM_020272 phosphoinositide-3-kinase, catalytic, gamma polypeptide (Pik3cg), mRNA [NM_020272] KLA .53 .53 .61 .64 .97 .86 .79
ATP 1.01 1.13 .88 .89 .52 .53 .53
KLA/ATP .58 .53 .43 .60 .40 .43 .62
Pik3r1
KLA  ATP  ATP+KLA
 NM_001077495 phosphatidylinositol 3-kinase, regulatory subunit, polypeptide 1 (p85 alpha) (Pik3r1), transcript variant 2, mRNA [NM_001077495] KLA 1.05 1.07 1.03 1.00 1.01 1.20 .85
ATP .97 1.02 1.48 1.42 1.76 1.33 1.23
KLA/ATP 1.11 1.12 1.06 1.17 1.24 .99 1.12
Pik3r2
KLA  ATP  ATP+KLA
 NM_008841 phosphatidylinositol 3-kinase, regulatory subunit, polypeptide 2 (p85 beta) (Pik3r2), mRNA [NM_008841] KLA .50 .50 .48 .43 .46 .66 .75
ATP .78 .68 .45 .43 .28 .57 1.37
KLA/ATP .49 .38 .32 .33 .38 .67 1.10
Pik3r3
KLA  ATP  ATP+KLA
 NM_181585 phosphatidylinositol 3 kinase, regulatory subunit, polypeptide 3 (p55) (Pik3r3), mRNA [NM_181585] KLA 1.59 1.49 1.37 1.17 1.05 1.55 1.41
ATP 1.12 1.00 1.33 1.70 2.01 2.37 2.02
KLA/ATP 1.63 1.54 1.58 1.70 2.43 2.68 1.92
Pik3r5
KLA  ATP  ATP+KLA
 NM_177320 phosphoinositide-3-kinase, regulatory subunit 5, p101 (Pik3r5), mRNA [NM_177320] KLA 3.57 3.58 4.16 3.54 4.11 2.59 2.39
ATP 1.08 1.08 .93 1.67 3.11 1.88 1.34
KLA/ATP 3.91 3.70 3.30 3.80 2.70 2.04 3.00
Pklr
KLA  ATP  ATP+KLA
 NM_013631 pyruvate kinase liver and red blood cell (Pklr), nuclear gene encoding mitochondrial protein, transcript variant 1, mRNA [NM_013631] KLA 1.06 1.01 1.12 1.00 .98 1.01 1.07
ATP .98 .94 1.05 1.06 1.01 1.06 1.10
KLA/ATP .97 1.00 1.04 .95 .89 1.05 .97
Ppargc1a
KLA  ATP  ATP+KLA
 AK032149 adult male olfactory brain cDNA, RIKEN full-length enriched library, clone:6430402E12 product:hypothetical protein, full insert sequence [AK032149] KLA .98 1.02 1.01 .93 .98 .97 .88
ATP .94 1.02 1.05 .95 .98 .99 1.05
KLA/ATP .96 1.01 1.01 1.02 1.01 .99 1.08
Ppargc1a
KLA  ATP  ATP+KLA
 NM_008904 peroxisome proliferative activated receptor, gamma, coactivator 1 alpha (Ppargc1a), mRNA [NM_008904] KLA .99 1.00 .91 .99 1.04 1.00 1.03
ATP 1.00 .93 1.02 1.01 1.04 1.07 1.03
KLA/ATP 1.03 .95 1.02 1.01 1.04 1.10 1.06
Ppp1ca
KLA  ATP  ATP+KLA
 NM_031868 protein phosphatase 1, catalytic subunit, alpha isoform (Ppp1ca), mRNA [NM_031868] KLA .89 .93 .93 .86 .95 1.07 1.20
ATP 1.04 1.07 .93 1.02 1.01 .89 1.10
KLA/ATP .98 .93 .74 .91 .84 1.01 1.34
Ppp1cb
KLA  ATP  ATP+KLA
 NM_172707 protein phosphatase 1, catalytic subunit, beta isoform (Ppp1cb), mRNA [NM_172707] KLA 1.12 1.08 1.05 1.02 .89 .84 .94
ATP .89 .87 .75 .55 .73 1.14 .69
KLA/ATP .92 .94 .80 .64 .64 .83 .65
Ppp1cc
KLA  ATP  ATP+KLA
 NM_013636 protein phosphatase 1, catalytic subunit, gamma isoform (Ppp1cc), mRNA [NM_013636] KLA .51 .51 .49 .48 .53 .64 .64
ATP 1.02 1.01 .85 .79 .72 .89 .95
KLA/ATP .54 .49 .42 .43 .56 .76 .81
Ppp1r3b
KLA  ATP  ATP+KLA
 NM_177741 protein phosphatase 1, regulatory (inhibitor) subunit 3B (Ppp1r3b), mRNA [NM_177741] KLA .53 .58 .62 .61 .65 .70 .65
ATP 1.04 .97 .80 .70 .79 .95 .91
KLA/ATP .60 .57 .59 .73 .83 .80 .61
Ppp1r3c
KLA  ATP  ATP+KLA
 NM_016854 protein phosphatase 1, regulatory (inhibitor) subunit 3C (Ppp1r3c), mRNA [NM_016854] KLA 1.00 .99 .98 1.07 1.01 .96 1.08
ATP 1.02 .99 .99 1.14 1.08 .98 1.01
KLA/ATP 1.00 1.02 .94 1.09 1.06 1.05 1.11
Ppp1r3d
KLA  ATP  ATP+KLA
 NM_001085501 protein phosphatase 1, regulatory subunit 3D (Ppp1r3d), mRNA [NM_001085501] KLA .83 .93 1.20 1.43 1.22 .96 .47
ATP .95 .70 .61 .27 .51 .92 .75
KLA/ATP .80 .58 .91 .69 1.84 .92 .39
Prkaa1
KLA  ATP  ATP+KLA
 NM_001013367 protein kinase, AMP-activated, alpha 1 catalytic subunit (Prkaa1), mRNA [NM_001013367] KLA 1.10 1.03 1.17 1.25 1.24 1.61 2.29
ATP 1.04 1.07 1.10 1.08 1.04 2.01 2.13
KLA/ATP 1.07 1.04 1.04 1.17 .95 1.90 3.90
Prkaa2
KLA  ATP  ATP+KLA
 NM_178143 protein kinase, AMP-activated, alpha 2 catalytic subunit (Prkaa2), mRNA [NM_178143] KLA .93 .94 .94 .90 .92 .92 .99
ATP 1.00 1.14 .93 1.01 1.00 1.11 .98
KLA/ATP 1.00 .97 .99 1.01 .98 1.02 .98
Prkab1
KLA  ATP  ATP+KLA
 NM_031869 protein kinase, AMP-activated, beta 1 non-catalytic subunit (Prkab1), mRNA [NM_031869] KLA .68 .70 .95 1.10 1.43 1.66 1.22
ATP 1.02 .93 .93 .95 .92 1.62 1.46
KLA/ATP .72 .73 .84 .85 1.12 1.68 2.36
Prkab2
KLA  ATP  ATP+KLA
 NM_182997 protein kinase, AMP-activated, beta 2 non-catalytic subunit (Prkab2), mRNA [NM_182997] KLA .55 .56 .46 .65 .78 .68 .59
ATP .95 .74 .78 1.43 2.06 1.50 .70
KLA/ATP .60 .49 .51 .65 1.36 .94 .58
Prkaca
KLA  ATP  ATP+KLA
 NM_008854 protein kinase, cAMP dependent, catalytic, alpha (Prkaca), mRNA [NM_008854] KLA .71 .74 .72 .70 .72 .84 .85
ATP 1.05 .98 .89 .92 .76 .60 1.02
KLA/ATP .79 .74 .55 .65 .60 .65 .93
Prkacb
KLA  ATP  ATP+KLA
 NM_011100 protein kinase, cAMP dependent, catalytic, beta (Prkacb), mRNA [NM_011100] KLA .69 .70 .66 .58 .51 .55 .59
ATP 1.02 1.19 .97 1.01 .69 .38 .56
KLA/ATP .72 .73 .57 .62 .47 .41 .45
Prkag1
KLA  ATP  ATP+KLA
 NM_016781 protein kinase, AMP-activated, gamma 1 non-catalytic subunit (Prkag1), mRNA [NM_016781] KLA .66 .70 .71 .83 .92 1.02 1.02
ATP 1.06 1.00 .97 1.04 .81 1.09 1.16
KLA/ATP .67 .74 .75 .74 .76 1.15 1.37
Prkag2
KLA  ATP  ATP+KLA
 NM_145401 protein kinase, AMP-activated, gamma 2 non-catalytic subunit (Prkag2), mRNA [NM_145401] KLA .41 .39 .30 .35 .30 .34 .45
ATP .88 .86 .65 .68 .46 .52 .47
KLA/ATP .39 .37 .32 .37 .38 .48 .30
Prkag3
KLA  ATP  ATP+KLA
 NM_153744 protein kinase, AMP-activated, gamma 3 non-catatlytic subunit (Prkag3), transcript variant 1, mRNA [NM_153744] KLA 1.01 .99 1.03 1.04 1.12 1.00 1.15
ATP .97 1.07 1.10 1.11 1.05 1.09 1.04
KLA/ATP 1.06 1.02 1.11 1.15 1.11 1.07 .98
Prkar1a
KLA  ATP  ATP+KLA
 NM_021880 protein kinase, cAMP dependent regulatory, type I, alpha (Prkar1a), mRNA [NM_021880] KLA 1.03 1.01 1.14 .97 1.05 .93 .85
ATP 1.14 1.32 1.06 1.24 1.00 .62 .68
KLA/ATP 1.16 1.24 .83 1.13 .84 .79 .48
Prkar1b
KLA  ATP  ATP+KLA
 NM_008923 protein kinase, cAMP dependent regulatory, type I beta (Prkar1b), mRNA [NM_008923] KLA 1.02 1.05 .85 .95 .90 .98 1.26
ATP 1.05 1.12 .95 1.12 1.12 1.06 1.23
KLA/ATP 1.00 .97 .81 .90 .93 1.06 1.05
Prkar2a
KLA  ATP  ATP+KLA
 NM_008924 protein kinase, cAMP dependent regulatory, type II alpha (Prkar2a), mRNA [NM_008924] KLA .70 .65 .56 .52 .41 .48 .82
ATP 1.05 1.27 .85 1.05 .74 .70 .84
KLA/ATP .71 .72 .45 .56 .41 .51 .71
Prkar2b
KLA  ATP  ATP+KLA
 NM_011158 protein kinase, cAMP dependent regulatory, type II beta (Prkar2b), mRNA [NM_011158] KLA .83 .76 .76 .67 .34 .43 .62
ATP .82 .79 1.08 .71 .69 2.46 .55
KLA/ATP .65 .74 .95 .63 .42 .70 1.19
Prkci
KLA  ATP  ATP+KLA
 NM_008857 protein kinase C, iota (Prkci), mRNA [NM_008857] KLA .92 .84 .75 .59 .50 .66 .90
ATP 1.06 1.20 1.15 1.10 1.14 1.04 1.00
KLA/ATP .83 .92 .75 .78 .99 1.06 .80
Prkcz
KLA  ATP  ATP+KLA
 NM_008860 protein kinase C, zeta (Prkcz), transcript variant 1, mRNA [NM_008860] KLA .92 .90 1.00 .99 1.07 1.05 1.12
ATP 1.01 .95 .94 .93 1.04 1.04 .95
KLA/ATP .95 .94 .95 .94 .99 1.02 .98
Prkx
KLA  ATP  ATP+KLA
 NM_016979 protein kinase, X-linked (Prkx), mRNA [NM_016979] KLA 3.61 3.79 4.67 4.66 4.85 4.19 1.43
ATP .98 .90 .63 .61 1.12 1.90 1.29
KLA/ATP 3.56 3.36 2.62 2.06 2.26 2.87 2.31
Ptpn1
KLA  ATP  ATP+KLA
 NM_011201 protein tyrosine phosphatase, non-receptor type 1 (Ptpn1), mRNA [NM_011201] KLA .91 .93 1.16 1.45 2.07 1.55 1.63
ATP 1.03 1.01 .83 .70 1.31 1.65 .92
KLA/ATP .93 .93 .98 1.02 1.99 2.02 1.03
Ptprf
KLA  ATP  ATP+KLA
 NM_011213 protein tyrosine phosphatase, receptor type, F (Ptprf), mRNA [NM_011213] KLA 1.28 1.42 1.29 1.27 1.17 1.19 1.27
ATP 1.09 1.11 1.27 1.29 1.53 2.24 2.95
KLA/ATP 1.31 1.42 1.28 1.33 1.25 1.50 1.60
Pygb
KLA  ATP  ATP+KLA
 NM_153781 brain glycogen phosphorylase (Pygb), mRNA [NM_153781] KLA .91 .83 .91 .78 .88 .87 .81
ATP 1.12 1.17 .92 1.03 .75 .51 .83
KLA/ATP .92 .91 .81 .88 .67 .61 .63
Pygl
KLA  ATP  ATP+KLA
 AK083075 12 days embryo spinal cord cDNA, RIKEN full-length enriched library, clone:C530044G15 product:weakly similar to GLYCOGEN PHOSPHORYLASE (EC 2.4.1.1) (ALPHA-GLUCAN PHOSPHORYLASE) (STARCH PHOSPHORYLASE) [Mus musculus], full insert sequence [ KLA .85 .87 .84 .91 .88 .84 .95
ATP 1.04 1.03 .99 1.07 .95 .80 .83
KLA/ATP .88 .88 .95 .97 .98 .87 .76
Pygl
KLA  ATP  ATP+KLA
 NM_133198 liver glycogen phosphorylase (Pygl), mRNA [NM_133198] KLA .79 .76 .73 .67 .52 .42 .66
ATP 1.01 .94 1.24 1.10 .92 .55 .44
KLA/ATP .76 .81 .93 .81 .76 .45 .14
Pygm
KLA  ATP  ATP+KLA
 NM_011224 muscle glycogen phosphorylase (Pygm), mRNA [NM_011224] KLA 1.11 1.08 .97 1.00 1.09 1.13 1.19
ATP 1.02 .98 .97 2.09 1.91 1.71 1.11
KLA/ATP 1.15 1.06 .87 1.65 1.87 1.99 1.42
Raf1
KLA  ATP  ATP+KLA
 AK036317 16 days neonate cerebellum cDNA, RIKEN full-length enriched library, clone:9630056E02 product:v-raf-1 leukemia viral oncogene 1, full insert sequence. [AK036317] KLA 1.47 1.34 1.55 1.29 1.59 1.32 1.46
ATP 1.05 .98 .54 .63 3.32 2.07 1.01
KLA/ATP 1.57 1.33 .79 .96 2.26 1.38 1.35
Raf1
KLA  ATP  ATP+KLA
 NM_029780 v-raf-leukemia viral oncogene 1 (Raf1), mRNA [NM_029780] KLA 1.65 1.64 1.93 1.77 1.77 1.72 1.81
ATP .95 .96 .83 .80 2.22 2.92 1.19
KLA/ATP 1.68 1.64 1.39 1.32 1.85 2.50 2.06
Rapgef1
KLA  ATP  ATP+KLA
 NM_001039087 Rap guanine nucleotide exchange factor (GEF) 1 (Rapgef1), transcript variant 1, mRNA [NM_001039087] KLA .93 .89 .88 .67 .73 .90 1.16
ATP 1.12 1.09 .82 1.25 1.43 1.63 1.58
KLA/ATP 1.03 .95 .67 .74 .65 .89 1.77
Rheb
KLA  ATP  ATP+KLA
 NM_053075 RAS-homolog enriched in brain (Rheb), mRNA [NM_053075] KLA 1.03 1.00 .99 .99 .95 1.03 1.09
ATP .99 .89 .95 .81 1.07 1.19 .90
KLA/ATP 1.01 .87 .97 .82 1.06 1.22 .88
Rhoq
KLA  ATP  ATP+KLA
 NM_145491 ras homolog gene family, member Q (Rhoq), mRNA [NM_145491] KLA .88 .85 1.14 1.67 2.93 2.44 2.37
ATP .96 .88 .93 .71 .86 .69 .85
KLA/ATP .83 .77 .83 .70 1.10 .54 .66
RP23-136
K12.4
KLA  ATP  ATP+KLA
 NM_008916 putative phosphatase (Pps), mRNA [NM_008916] KLA 1.35 1.47 1.81 1.90 2.21 2.28 1.37
ATP 1.00 1.04 1.03 1.11 .86 .77 1.25
KLA/ATP 1.45 1.56 1.59 1.74 1.57 1.45 2.55
Rps6
KLA  ATP  ATP+KLA
 AK013825 adult male hippocampus cDNA, RIKEN full-length enriched library, clone:2900086I01 product:ribosomal protein S6, full insert sequence. [AK013825] KLA 1.04 1.06 1.03 .99 .94 .96 1.26
ATP 1.01 1.00 1.04 .99 .99 .94 1.12
KLA/ATP 1.02 1.08 .95 1.04 .94 .97 .90
Rps6
KLA  ATP  ATP+KLA
 NM_009096 ribosomal protein S6 (Rps6), mRNA [NM_009096] KLA 1.01 1.01 .94 .87 .89 .66 .72
ATP 1.11 1.07 1.10 1.12 1.12 1.03 .47
KLA/ATP .96 1.04 1.22 1.10 .86 .84 .40
Rps6kb1
KLA  ATP  ATP+KLA
 NM_001114334 ribosomal protein S6 kinase, polypeptide 1 (Rps6kb1), transcript variant 1, mRNA [NM_001114334] KLA .99 1.00 .90 .89 .99 .99 .92
ATP 1.01 .96 1.00 .79 1.36 1.19 .72
KLA/ATP 1.08 .99 .93 .92 1.18 .90 .56
Rps6kb1
KLA  ATP  ATP+KLA
 NM_028259 ribosomal protein S6 kinase, polypeptide 1 (Rps6kb1), transcript variant 2, mRNA [NM_028259] KLA 1.01 .93 1.07 1.04 .99 .99 .98
ATP 1.09 1.05 1.00 1.01 1.08 1.03 1.03
KLA/ATP 1.07 1.04 .94 .98 1.03 1.05 1.05
Rps6kb2
KLA  ATP  ATP+KLA
 AK090093 kidney CCL-142 RAG cDNA, RIKEN full-length enriched library, clone:G430107K15 product:ribosomal protein S6 kinase, 70kD, polypeptide 2, full insert sequence [AK090093] KLA .97 1.01 .98 .97 .98 1.04 1.07
ATP 1.00 1.08 1.06 1.09 1.11 1.06 1.03
KLA/ATP 1.05 .96 .86 1.03 1.40 1.07 .99
Rps6kb2
KLA  ATP  ATP+KLA
 NM_021485 ribosomal protein S6 kinase, polypeptide 2 (Rps6kb2), mRNA [NM_021485] KLA 1.36 1.40 1.45 1.40 1.63 1.57 1.46
ATP 1.08 1.19 .97 1.15 .90 .99 1.34
KLA/ATP 1.44 1.55 1.09 1.39 1.00 1.12 1.77
Sh2b2
KLA  ATP  ATP+KLA
 NM_018825 SH2B adaptor protein 2 (Sh2b2), mRNA [NM_018825] KLA .89 .94 .95 1.10 1.67 1.80 1.78
ATP 1.03 1.15 1.05 1.62 4.24 2.85 1.90
KLA/ATP 1.03 .97 .88 1.41 2.83 3.50 3.87
Shc1
KLA  ATP  ATP+KLA
 NM_011368 src homology 2 domain-containing transforming protein C1 (Shc1), transcript variant 2, mRNA [NM_011368] KLA .88 .87 .86 .83 1.09 1.11 1.12
ATP 1.04 1.25 .85 1.17 .93 1.16 1.00
KLA/ATP .93 .96 .62 .96 .75 1.25 1.19
Shc2
KLA  ATP  ATP+KLA
 NM_001024539 src homology 2 domain-containing transforming protein C2 (Shc2), mRNA [NM_001024539] KLA 1.19 1.25 1.22 1.16 1.15 1.14 .98
ATP 1.04 1.14 1.15 1.53 1.29 1.06 1.09
KLA/ATP 1.26 1.24 1.26 1.49 1.31 1.30 1.30
Shc3
KLA  ATP  ATP+KLA
 NM_009167 src homology 2 domain-containing transforming protein C3 (Shc3), mRNA [NM_009167] KLA 1.00 .98 1.06 1.06 1.12 1.08 1.04
ATP .99 1.02 1.00 1.05 1.00 1.08 1.08
KLA/ATP 1.08 1.06 1.01 1.06 1.03 1.12 1.41
Shc4
KLA  ATP  ATP+KLA
 NM_199022 SHC (Src homology 2 domain containing) family, member 4 (Shc4), mRNA [NM_199022] KLA 1.03 1.03 1.01 1.06 1.09 1.03 1.06
ATP .99 1.00 1.03 1.02 1.04 1.04 1.01
KLA/ATP .98 .97 1.06 1.05 1.00 1.00 1.14
Slc2a4
KLA  ATP  ATP+KLA
 NM_009204 solute carrier family 2 (facilitated glucose transporter), member 4 (Slc2a4), mRNA [NM_009204] KLA 1.08 1.10 1.09 1.10 1.08 1.01 .98
ATP 1.02 .98 1.01 1.02 .98 .96 1.00
KLA/ATP 1.07 1.08 1.07 1.06 1.03 1.01 .99
Socs1
KLA  ATP  ATP+KLA
 NM_009896 suppressor of cytokine signaling 1 (Socs1), mRNA [NM_009896] KLA 27.36 22.16 20.64 23.08 17.74 21.71 10.12
ATP .91 .72 2.03 12.69 9.16 19.87 6.80
KLA/ATP 26.70 24.56 28.15 31.28 26.32 29.95 22.51
Socs2
KLA  ATP  ATP+KLA
 AK033206 15 days embryo male testis cDNA, RIKEN full-length enriched library, clone:8030460M17 product:hypothetical SH2 motif [AK033206] KLA 1.08 1.11 1.22 1.13 1.11 1.08 .97
ATP .98 .97 1.03 1.03 1.29 1.30 1.29
KLA/ATP 1.06 1.09 1.07 1.33 2.01 1.85 1.98
Socs2
KLA  ATP  ATP+KLA
 NM_007706 suppressor of cytokine signaling 2 (Socs2), mRNA [NM_007706] KLA 2.03 2.28 2.61 1.98 1.59 1.72 1.28
ATP 1.04 1.04 1.05 1.17 2.11 3.47 3.02
KLA/ATP 2.18 1.92 1.71 2.33 3.37 5.81 4.64
Socs3
KLA  ATP  ATP+KLA
 NM_007707 suppressor of cytokine signaling 3 (Socs3), mRNA [NM_007707] KLA 7.56 6.68 6.29 7.36 6.47 7.03 5.33
ATP 1.51 1.75 4.63 6.27 6.92 7.74 4.64
KLA/ATP 6.82 6.77 9.19 8.32 9.51 8.98 8.33
Socs4
KLA  ATP  ATP+KLA
 AK080408 7 days neonate cerebellum cDNA, RIKEN full-length enriched library, clone:A730004F22 product:unclassifiable, full insert sequence [AK080408] KLA .89 .90 .87 .74 .87 1.05 .98
ATP 1.01 .97 1.11 .76 1.00 .82 1.11
KLA/ATP .80 .82 .82 .70 1.00 .80 .76
Socs4
KLA  ATP  ATP+KLA
 NM_080843 suppressor of cytokine signaling 4 (Socs4), mRNA [NM_080843] KLA 1.31 1.29 1.45 1.31 1.42 1.90 2.37
ATP 1.02 1.16 1.31 1.39 1.86 2.43 2.69
KLA/ATP 1.33 1.24 1.26 1.31 1.39 2.94 3.73
Sorbs1
KLA  ATP  ATP+KLA
 NM_178362 sorbin and SH3 domain containing 1 (Sorbs1), transcript variant 2, mRNA [NM_178362] KLA .92 .85 .90 .76 .93 .86 .86
ATP .96 1.02 .95 .73 .70 1.05 .79
KLA/ATP .86 .85 .93 .70 .74 1.25 1.40
Sos1
KLA  ATP  ATP+KLA
 NM_009231 Son of sevenless homolog 1 (Drosophila) (Sos1), mRNA [NM_009231] KLA 2.36 2.40 3.42 3.15 2.78 1.81 1.71
ATP .99 1.00 .99 1.15 1.14 1.25 1.24
KLA/ATP 2.41 2.26 1.95 2.44 1.47 1.66 1.37
Sos2
KLA  ATP  ATP+KLA
 XM_127051 gb|PREDICTED: Mus musculus Son of sevenless homolog 2 (Drosophila) (Sos2), mRNA [XM_127051] KLA .81 .77 .79 .92 1.04 1.06 1.20
ATP 1.00 1.00 1.09 .79 .68 .81 .94
KLA/ATP .77 .69 .71 .60 .64 .77 1.07
Srebf1
KLA  ATP  ATP+KLA
 NM_011480 sterol regulatory element binding transcription factor 1 (Srebf1), mRNA [NM_011480] KLA .58 .53 .54 .53 .62 .65 .84
ATP .99 1.04 .99 1.00 .78 .75 .88
KLA/ATP .58 .53 .52 .52 .47 .50 .49
Trip10
KLA  ATP  ATP+KLA
 NM_134125 thyroid hormone receptor interactor 10 (Trip10), mRNA [NM_134125] KLA 3.41 3.14 3.00 1.86 1.18 .99 1.12
ATP 1.06 1.09 1.01 1.48 2.79 1.67 .90
KLA/ATP 3.71 3.95 2.99 3.72 2.94 1.46 .93
Tsc1
KLA  ATP  ATP+KLA
 AK083363 2 days neonate thymus thymic cells cDNA, RIKEN full-length enriched library, clone:C920023H23 product:tuberous sclerosis 1, full insert sequence. [AK083363] KLA .69 .66 .60 .71 .85 .78 .77
ATP 1.13 1.26 1.70 2.23 1.77 .87 .90
KLA/ATP .76 .77 .90 1.19 1.74 .80 .72
Tsc1
KLA  ATP  ATP+KLA
 NM_022887 tuberous sclerosis 1 (Tsc1), mRNA [NM_022887] KLA .93 .94 1.00 1.04 1.01 .95 1.10
ATP 1.12 1.10 1.12 1.27 1.66 1.45 1.80
KLA/ATP .95 1.00 1.06 1.03 1.26 1.30 1.74
Tsc2
KLA  ATP  ATP+KLA
 NM_011647 tuberous sclerosis 2 (Tsc2), transcript variant 1, mRNA [NM_011647] KLA .91 .88 .87 .83 .83 .88 .99
ATP .91 .91 1.04 .88 .76 .68 .91
KLA/ATP .88 .89 .88 .76 .65 .67 .85